Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1992 June 1; 175(6): 1443–1447.
PMCID: PMC2119242

Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells


Murine bone marrow Lin-, Ly6A/E+ cells have been fractionated on the basis of rhodamine123 retention into Rh123med/hi and Rh123lo subpopulations. These populations have different responses to hemopoietic growth factors with respect to in vitro colony formation. Cells from either fraction were not stimulated by only granulocyte- colony-stimulating factor (G-CSF), granulocyte/macrophage colony- stimulating factor (GM-CSF), macrophage colony-stimulating factor (M- CSF), interleukins 1 and 6 (IL-1 and -6), or leukemia inhibitory factor (LIF) alone. The Rh123med/hi, but not the Rh123lo fraction, contained cells that could be stimulated by either stem cell factor (SCF) or IL-3 alone. When combinations of growth factors were added, the Rh123med/hi fraction produced more colonies, and responded to a wider range of factor combinations than the Rh123lo population. When tested in vivo, both populations contained no detectable day 8 colony-forming unit- spleen (CFU-S), and similar frequencies of day 13 CFU-S. When transplanted into lethally irradiated recipients (100 cells/recipient), significant numbers of donor cells (67-73%) were found in the peripheral blood of Rh123lo recipients. Both myeloid and lymphoid cells were of donor origin. By comparison, the Rh123med/hi population produced recipients with 1-2% donor cells in peripheral blood, the majority of which were lymphoid.

Full Text

The Full Text of this article is available as a PDF (427K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lord BI, Dexter TM. Purification of haemopoietic stem cells--the end of the road? Immunol Today. 1988 Dec;9(12):376–377. [PubMed]
  • Iscove N. Haematopoiesis. Searching for stem cells. Nature. 1990 Sep 13;347(6289):126–127. [PubMed]
  • Spangrude GJ. Enrichment of murine haemopoietic stem cells: diverging roads. Immunol Today. 1989 Oct;10(10):344–350. [PubMed]
  • Visser JW, Van Bekkum DW. Purification of pluripotent hemopoietic stem cells: past and present. Exp Hematol. 1990 Mar;18(3):248–256. [PubMed]
  • Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, Friedman J, Weissman IL. Mouse hematopoietic stem cells. Blood. 1991 Sep 15;78(6):1395–1402. [PubMed]
  • Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2788–2792. [PubMed]
  • Spangrude GJ, Johnson GR. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7433–7437. [PubMed]
  • Spangrude GJ, Scollay R. A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol. 1990 Sep;18(8):920–926. [PubMed]
  • Bertoncello I, Hodgson GS, Bradley TR. Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol. 1985 Nov;13(10):999–1006. [PubMed]
  • Heimfeld S, Hudak S, Weissman I, Rennick D. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9902–9906. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press